Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 208 (RNA5SP208) is a processed pseudogene derived from the 5S ribosomal RNA gene family[3][2]. Pseudogenes such as RNA5SP208 are segments of DNA that resemble functional genes but are generally nonfunctional, as they usually do not encode a functional RNA or protein product. 5S ribosomal RNA itself is a well-characterized structural component of the large ribosomal subunit, crucial for ribosome architecture and indirectly supporting protein synthesis[1][5]. However, pseudogenes like RNA5SP208 lack the necessary sequences for biological activity or participation in normal ribosome function.\nPseudogenes may occasionally have regulatory effects on gene expression (for example, acting as competing endogenous RNAs or influencing the regulation of their parent gene through RNA-mediated mechanisms), and their expression patterns have sometimes been implicated in cancer subgroup stratification in large-scale genomics studies[4]. However, there is no evidence that RNA5SP208 encodes a protein or functions as a therapeutic target, receptor, or biomarker, and it is not a drug-interacted molecule.\n\nKey points:\n- Pseudogenes are typically excluded from lists of valid therapeutic targets because they are generally nonfunctional genetic remnants[2][3].\n- There is no evidence for any druggability or role in disease etiology for RNA5SP208.\n- The target name is correct for a pseudogene, but as a pseudogene it does not fit the class of proteins or RNAs that are conventional molecular targets or receptors.\n- RNA5SP208 may occasionally be included as a feature in computational studies of cancer based on global expression profiling, but this does not confer a direct functional or druggable role[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 208 (RNA5SP208).